Enhanced Glioma Genotype Prediction Using CEST MRI With Full Z-Spectrum Input, Pixel-Level Learning, and Majority Voting.

IF 2.8 4区 医学 Q2 BIOPHYSICS
Zhekai Chen, Jue Lu, Xinli Zhang, Jing Wang, Lin Chen
{"title":"Enhanced Glioma Genotype Prediction Using CEST MRI With Full Z-Spectrum Input, Pixel-Level Learning, and Majority Voting.","authors":"Zhekai Chen, Jue Lu, Xinli Zhang, Jing Wang, Lin Chen","doi":"10.1002/nbm.70269","DOIUrl":null,"url":null,"abstract":"<p><p>Accurate glioma genotype prediction, such as the isocitrate dehydrogenase (IDH) mutation and O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation status, is critical for personalized treatment planning and prognosis. Chemical exchange saturation transfer (CEST) MRI enables noninvasive assessment of tumor metabolism and the microenvironment, offering promising potential for genotype prediction. However, existing CEST-based diagnostic methods are limited by information loss from simplified quantification and by instability arising from ROI-dependent analysis. To address these limitations, a deep learning framework was developed that integrates the full Z-spectrum input, pixel-level training, and a majority voting mechanism to improve prediction accuracy and robustness. In a cohort of 84 patients, a feedforward neural network (FNN) was trained to process the entire Z-spectrum and generate pixel-wise predictions, which were subsequently aggregated into patient-level outcomes through majority voting. T-distributed stochastic neighbor embedding (t-SNE) was applied to evaluate the effectiveness of the full Z-spectrum input. Model generalizability and robustness were assessed using fivefold cross-validation, and stability was quantified via the coefficient of variation (CoV). Prediction performance was evaluated in terms of accuracy, sensitivity, specificity, and the area under the curve (AUC). The proposed method demonstrated improved interclass separability with the full Z-spectrum input (t-SNE score: 64.50), outperforming APTw (55.60) and Lorentzian fitting (56.97). Stable prediction performance was achieved for both IDH (accuracy: 0.86 ± 0.04 and AUC: 0.91 ± 0.03) and MGMT (accuracy: 0.82 ± 0.02 and AUC: 0.91 ± 0.04) genotypes. The approach also showed strong robustness to ROI selection, with a CoV of 0.69%, compared to 7.44% for APTw-mean and 3.67% for Lorentzian fitting (LF-mean). These findings support the effectiveness of combining the full Z-spectrum input, pixel-level learning, and majority voting to improve the reliability of noninvasive glioma genotype prediction using CEST MRI.</p>","PeriodicalId":19309,"journal":{"name":"NMR in Biomedicine","volume":"39 4","pages":"e70269"},"PeriodicalIF":2.8000,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NMR in Biomedicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/nbm.70269","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOPHYSICS","Score":null,"Total":0}
引用次数: 0

Abstract

Accurate glioma genotype prediction, such as the isocitrate dehydrogenase (IDH) mutation and O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation status, is critical for personalized treatment planning and prognosis. Chemical exchange saturation transfer (CEST) MRI enables noninvasive assessment of tumor metabolism and the microenvironment, offering promising potential for genotype prediction. However, existing CEST-based diagnostic methods are limited by information loss from simplified quantification and by instability arising from ROI-dependent analysis. To address these limitations, a deep learning framework was developed that integrates the full Z-spectrum input, pixel-level training, and a majority voting mechanism to improve prediction accuracy and robustness. In a cohort of 84 patients, a feedforward neural network (FNN) was trained to process the entire Z-spectrum and generate pixel-wise predictions, which were subsequently aggregated into patient-level outcomes through majority voting. T-distributed stochastic neighbor embedding (t-SNE) was applied to evaluate the effectiveness of the full Z-spectrum input. Model generalizability and robustness were assessed using fivefold cross-validation, and stability was quantified via the coefficient of variation (CoV). Prediction performance was evaluated in terms of accuracy, sensitivity, specificity, and the area under the curve (AUC). The proposed method demonstrated improved interclass separability with the full Z-spectrum input (t-SNE score: 64.50), outperforming APTw (55.60) and Lorentzian fitting (56.97). Stable prediction performance was achieved for both IDH (accuracy: 0.86 ± 0.04 and AUC: 0.91 ± 0.03) and MGMT (accuracy: 0.82 ± 0.02 and AUC: 0.91 ± 0.04) genotypes. The approach also showed strong robustness to ROI selection, with a CoV of 0.69%, compared to 7.44% for APTw-mean and 3.67% for Lorentzian fitting (LF-mean). These findings support the effectiveness of combining the full Z-spectrum input, pixel-level learning, and majority voting to improve the reliability of noninvasive glioma genotype prediction using CEST MRI.

使用全z谱输入、像素级学习和多数投票的CEST MRI增强胶质瘤基因型预测。
准确的胶质瘤基因型预测,如异柠檬酸脱氢酶(IDH)突变和o6 -甲基鸟嘌呤- dna甲基转移酶(MGMT)启动子甲基化状态,对个性化治疗计划和预后至关重要。化学交换饱和转移(CEST) MRI能够无创评估肿瘤代谢和微环境,为基因型预测提供了有希望的潜力。然而,现有的基于cest的诊断方法受到简化量化带来的信息损失和roi依赖分析带来的不稳定性的限制。为了解决这些限制,开发了一个深度学习框架,该框架集成了全z谱输入、像素级训练和多数投票机制,以提高预测准确性和鲁棒性。在84名患者的队列中,训练前馈神经网络(FNN)来处理整个z谱并生成像素预测,随后通过多数投票将其汇总为患者级结果。采用t分布随机邻居嵌入(t-SNE)来评估全z谱输入的有效性。采用五重交叉验证评估模型的通用性和稳健性,并通过变异系数(CoV)量化模型的稳定性。从准确性、敏感性、特异性和曲线下面积(AUC)等方面评价预测效果。该方法在全z谱输入下具有更好的类间可分性(t-SNE得分:64.50),优于APTw(55.60)和Lorentzian拟合(56.97)。对IDH(精度:0.86±0.04,AUC: 0.91±0.03)和MGMT(精度:0.82±0.02,AUC: 0.91±0.04)基因型均具有稳定的预测性能。该方法对ROI选择也表现出很强的稳健性,CoV为0.69%,而APTw-mean的CoV为7.44%,Lorentzian拟合(LF-mean)的CoV为3.67%。这些发现支持将全z谱输入、像素级学习和多数投票相结合的有效性,以提高使用CEST MRI进行非侵入性胶质瘤基因型预测的可靠性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
NMR in Biomedicine
NMR in Biomedicine 医学-光谱学
CiteScore
6.00
自引率
10.30%
发文量
209
审稿时长
3-8 weeks
期刊介绍: NMR in Biomedicine is a journal devoted to the publication of original full-length papers, rapid communications and review articles describing the development of magnetic resonance spectroscopy or imaging methods or their use to investigate physiological, biochemical, biophysical or medical problems. Topics for submitted papers should be in one of the following general categories: (a) development of methods and instrumentation for MR of biological systems; (b) studies of normal or diseased organs, tissues or cells; (c) diagnosis or treatment of disease. Reports may cover work on patients or healthy human subjects, in vivo animal experiments, studies of isolated organs or cultured cells, analysis of tissue extracts, NMR theory, experimental techniques, or instrumentation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书